Investigation the Safety and Efficacy of The Antileukotriene Agents, Montelukast, as Adjuvant Therapy in Obese Patients With Type 2 Diabetes Mellitus

Inclusion Criteria: \- type 2 diabetic patients who had body mass index (BMI) ≥ 30 kg/m2 , were treated with metformin alone and had ages ranging from 18 to 60 years. Exclusion Criteria: * patients who had any other inflammatory disease * patients with cardiovascular, * patients with asthma * patients with severe hepatic * patients with renal disease, * patients with epilepsy * pregnant or lactating females.